Inhibrx Biosciences INBX
NASDAQ INBX
$100.32 -4.51 (-4.30%)
As of: Sep 30, 2026 · 3:59 PM EDT

Inhibrx Biosciences (INBX) Capital Expenditures (2023 - 2025)

Updated

Inhibrx Biosciences (INBX) posted Capital Expenditures of $31,000 for FY2025, down 98.8% from $2.6 million in FY2024.

Analysis

Inhibrx Biosciences (INBX) Capital Expenditures (2023 - 2025) Analysis & Trends

  • Business Quant data shows INBX's Capital Expenditures at $2.6 million in FY2024 (-43.5%) and $4.59 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Inhibrx Biosciences 1.54 Bn 1.54 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 10,000.00
Mar 31, 2025 21,000.00
Dec 31, 2024 16,000.00
Sep 30, 2024 247,000.00
Jun 30, 2024 1.22 Mn
Mar 31, 2024 1.12 Mn
Dec 31, 2023 3.44 Mn
Sep 30, 2023 811,000.00
API Access

Inhibrx Biosciences Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INBX&period=max&api_key=YOUR_API_KEY